Outgrowth of human liver metastases after resection of the primary colorectal tumor: A shift in the balance between apoptosis and proliferation

Rapid outgrowth of metastases after removal of the primary tumor has been described in several mouse models. Loss of primary tumor‐induced inhibition of angiogenesis in the metastases has been suggested as the underlying cause. Accordingly, we recently demonstrated that vascular density in human colorectal liver metastases increases after primary tumor resection. Here, we investigate whether this increase in vascular density has, in its turn, effects on the tumor growth of the liver metastases. We analyzed tumor growth in synchronous liver metastases from patients with the primary tumor in place, in synchronous metastases from patients with the primary tumor resected and in metachronous metastases. Tumor growth was studied by assessing the percentage of cells undergoing apoptosis by activated caspase‐3 staining, and the percentage of proliferating cells by Ki‐67 staining. While the percentage of proliferating cells within the metastases showed a modest increase after primary tumor resection, a significant decrease in the percentage of apoptotic cells was observed. Taken together, an increased net tumor growth of the metastases occurred after primary tumor resection. This acceleration of tumor growth could be confirmed by studying biopsies taken from the same patient before and after tumor resection. Our data show that in human cancer patients, a primary tumor may inhibit the growth of its liver metastases. © 2006 Wiley‐Liss, Inc.

[1]  K. Camphausen,et al.  Radiation therapy to a primary tumor accelerates metastatic growth in mice. , 2001, Cancer research.

[2]  Lars Holmgren,et al.  Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression , 1995, Nature Medicine.

[3]  W. Oyen,et al.  Decrease in circulating anti-angiogenic factors (angiostatin and endostatin) after surgical removal of primary colorectal carcinoma coincides with increased metabolic activity of liver metastases. , 2005, Surgery.

[4]  O. Volpert,et al.  Signals leading to apoptosis-dependent inhibition of neovascularization by thrombospondin-1 , 2000, Nature Medicine.

[5]  William Arbuthnot Sir Lane,et al.  Endostatin: An Endogenous Inhibitor of Angiogenesis and Tumor Growth , 1997, Cell.

[6]  William Arbuthnot Sir Lane,et al.  Antiangiogenic activity of the cleaved conformation of the serpin antithrombin. , 1999, Science.

[7]  T. K. Das Gupta,et al.  Thin malignant melanomas with regression and metastases. , 1987, Archives of dermatology.

[8]  I. B. Borel Rinkes,et al.  Continuous administration of angiostatin inhibits accelerated growth of colorectal liver metastases after partial hepatectomy. , 2000, Cancer research.

[9]  K. Hamano,et al.  The influence of tumour resection on angiostatin levels and tumour growth--an experimental study in tumour-bearing mice. , 2001, European journal of cancer.

[10]  Lars Holmgren,et al.  Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinoma , 1994, Cell.

[11]  J. Folkman.  Angiogenesis in cancer, vascular, rheumatoid and other disease , 1995, Nature Medicine.

[12]  C. Murray.  Tumour dormancy: not so sleepy after all , 1995, Nature Medicine.

[13]  L Simpson-Herren,et al.  Effects of surgery on the cell kinetics of residual tumor. , 1976, Cancer treatment reports.

[14]  J. Berlin,et al.  Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. , 2004, The New England journal of medicine.

[15]  T. Wobbes,et al.  Vascular density in colorectal liver metastases increases after removal of the primary tumor in human cancer patients , 2004, International journal of cancer.

[16]  S. Thorgeirsson,et al.  Disruption of the pRb/E2F pathway and inhibition of apoptosis are major oncogenic events in liver constitutively expressing c-myc and transforming growth factor alpha. , 1998, Cancer research.

[17]  Y. Mitsumoto,et al.  Novel formula for cell kinetics in xenograft model of hepatocellular carcinoma using histologically calculable parameters. , 1999, Experimental cell research.

[18]  N Gunduz,et al.  Influence of the interval between primary tumor removal and chemotherapy on kinetics and growth of metastases. , 1983, Cancer research.

[19]  J. Folkman,et al.  Angiostatin induces and sustains dormancy of human primary tumors in mice , 1996, Nature Medicine.

[20]  T. Pawlik,et al.  Mouse endostatin inhibits the formation of lung and liver metastases. , 1999, Cancer research.

[21]  Ricky T. Tong,et al.  Direct evidence that the VEGF-specific antibody bevacizumab has antivascular effects in human rectal cancer , 2004, Nature Medicine.

[22]  R. Strange,et al.  Apoptosis in the genesis and prevention of cancer. , 1992, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[23]  R K Jain,et al.  Primary tumor size-dependent inhibition of angiogenesis at a secondary site: an intravital microscopic study in mice. , 1998, Cancer research.

[24]  K. Hillan,et al.  Importance of VEGF for breast cancer angiogenesis in vivo: implications from intravital microscopy of combination treatments with an anti-VEGF neutralizing monoclonal antibody and doxorubicin. , 1999, Anticancer research.

[25]  P. Carmeliet,et al.  Angiogenesis in cancer and other diseases , 2000, Nature.

[26]  J. Folkman.  Role of angiogenesis in tumor growth and metastasis. , 2002, Seminars in oncology.